Advances in Nanogels for Topical Drug Delivery in Ocular Diseases

Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulti...

Full description

Bibliographic Details
Main Authors: Yongkang Wu, Qing Tao, Jing Xie, Lili Lu, Xiuli Xie, Yang Zhang, Yong Jin
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/9/4/292
_version_ 1827745041081171968
author Yongkang Wu
Qing Tao
Jing Xie
Lili Lu
Xiuli Xie
Yang Zhang
Yong Jin
author_facet Yongkang Wu
Qing Tao
Jing Xie
Lili Lu
Xiuli Xie
Yang Zhang
Yong Jin
author_sort Yongkang Wu
collection DOAJ
description Nanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulting in a short retention time and low drug bioavailability, which is a significant challenge for physicians, patients, and pharmacists. Nanogels, however, have the ability to encapsulate drugs within three-dimensional crosslinked polymeric networks and, through specific structural designs and distinct methods of preparation, achieve the controlled and sustained delivery of loaded drugs, increasing patient compliance and therapeutic efficiency. In addition, nanogels have higher drug-loading capacity and biocompatibility than other nanocarriers. In this review, the main focus is on the applications of nanogels for ocular diseases, whose preparations and stimuli-responsive behaviors are briefly described. The current comprehension of topical drug delivery will be improved by focusing on the advances of nanogels in typical ocular diseases, including glaucoma, cataracts, dry eye syndrome, and bacterial keratitis, as well as related drug-loaded contact lenses and natural active substances.
first_indexed 2024-03-11T05:00:32Z
format Article
id doaj.art-d4580d1762a44bcbbcd06c04ee2964f3
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-11T05:00:32Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-d4580d1762a44bcbbcd06c04ee2964f32023-11-17T19:21:23ZengMDPI AGGels2310-28612023-04-019429210.3390/gels9040292Advances in Nanogels for Topical Drug Delivery in Ocular DiseasesYongkang Wu0Qing Tao1Jing Xie2Lili Lu3Xiuli Xie4Yang Zhang5Yong Jin6School of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaSchool of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei 230032, ChinaNanotechnology has accelerated the development of the pharmaceutical and medical technology fields, and nanogels for ocular applications have proven to be a promising therapeutic strategy. Traditional ocular preparations are restricted by the anatomical and physiological barriers of the eye, resulting in a short retention time and low drug bioavailability, which is a significant challenge for physicians, patients, and pharmacists. Nanogels, however, have the ability to encapsulate drugs within three-dimensional crosslinked polymeric networks and, through specific structural designs and distinct methods of preparation, achieve the controlled and sustained delivery of loaded drugs, increasing patient compliance and therapeutic efficiency. In addition, nanogels have higher drug-loading capacity and biocompatibility than other nanocarriers. In this review, the main focus is on the applications of nanogels for ocular diseases, whose preparations and stimuli-responsive behaviors are briefly described. The current comprehension of topical drug delivery will be improved by focusing on the advances of nanogels in typical ocular diseases, including glaucoma, cataracts, dry eye syndrome, and bacterial keratitis, as well as related drug-loaded contact lenses and natural active substances.https://www.mdpi.com/2310-2861/9/4/292nanogelsocular diseasesdrug delivery systemsnatural polymerscontact lenses
spellingShingle Yongkang Wu
Qing Tao
Jing Xie
Lili Lu
Xiuli Xie
Yang Zhang
Yong Jin
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
Gels
nanogels
ocular diseases
drug delivery systems
natural polymers
contact lenses
title Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_full Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_fullStr Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_full_unstemmed Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_short Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
title_sort advances in nanogels for topical drug delivery in ocular diseases
topic nanogels
ocular diseases
drug delivery systems
natural polymers
contact lenses
url https://www.mdpi.com/2310-2861/9/4/292
work_keys_str_mv AT yongkangwu advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT qingtao advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT jingxie advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT lililu advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT xiulixie advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT yangzhang advancesinnanogelsfortopicaldrugdeliveryinoculardiseases
AT yongjin advancesinnanogelsfortopicaldrugdeliveryinoculardiseases